Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04953832 · ClinicalTrials.gov registry record · NA
Neurotherapeutics as an Adjunctive Approach to Enhance Exposure Outcomes in Anxiety
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04953832 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 30 participants.
The verdict
NCT04953832, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Anxiety disorders are highly prevalent and costly to the individual and society. Exposure-based cognitive behavioral therapy (CBT) is the gold-standard intervention for anxiety disorders, although this approach does not fully reduce symptoms for all individuals. Therefore there is a need for innovative intervention approaches. One approach to augment and improve existing therapies would be to enhance the neurocognitive basis of fear extinction processes, which are the model on which treatments are based. Enhancing these processes may be possible through computerized cognitive training techniques which target executive functioning, the cognitive processes that help people manage complex cognitive activities. The proposed project is a proof-of-concept pilot study investigating the potential for training of executive functioning to improve anxiety-related outcomes. Individuals with elevated levels of social anxiety will be randomized to single-session COGnitive Enhancement Training (COGENT) or sham training program (ST). All participants will complete a single speech session where they present three 7-minute impromptu speeches and rate their anxiety at specific intervals. Participants will then complete the COGENT paradigm and affective processing task while undergoing fMRI.
Interventions
- BEHAVIORAL Cognitive Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2021-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04953832
The ClinicalTrials.gov registry entry for NCT04953832 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Training is the first listed.
NCT04953832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04953832 about?
NCT04953832 is a clinical study titled "Neurotherapeutics as an Adjunctive Approach to Enhance Exposure Outcomes in Anxiety". Anxiety disorders are highly prevalent and costly to the individual and society. Exposure-based cognitive behavioral therapy (CBT) is the gold-standard intervention for anxiety disorders, although this approach does not fully reduce symptoms for all individuals. Therefore there is a need for innovat...
What is the current status of trial NCT04953832?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-11-01. Estimated completion is 2021-09-01.
What interventions are being tested in trial NCT04953832?
The interventions under investigation include: Cognitive Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04953832?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.